GO:1990825 sequence-specific mRNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990825 sequence-specific mRNA binding describes the molecular function of binding to messenger RNA (mRNA) in a manner that depends on a specific nucleotide sequence or composition, rather than on bulk RNA charge or length.
• Sequence-specific mRNA binding is a core recognition step in mRNA processing, stability, localization, and translation, and it is often mediated by RNA-binding proteins or by structured RNA elements.
• Some sequence-specific mRNA-binding activities are carried out by proteins that lack canonical RNA-binding domains, but such cases are rarely sequence-specific, highlighting the importance of domain-based recognition.
• Toxin-antitoxin mRNA interferases are classic examples of sequence-specific endoribonucleases that bind and cleave mRNA at defined motifs.
• Sequence-specific mRNA binding can be modulated by RNA-RNA interactions, as shown for MALAT1, which regulates mRNA processing through sequence-dependent RNA-RNA and RNA-protein contacts.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of sequence-specific mRNA-binding proteins and their motifs in disease-relevant contexts.
Description
GO:1990825 sequence-specific mRNA binding is a molecular function defined as binding to messenger RNA (mRNA) of a specific nucleotide composition or a specific sequence motif. This term captures the selective recognition of mRNA molecules by proteins or RNA complexes, distinguishing it from nonspecific electrostatic interactions with RNA. Sequence-specific mRNA binding underlies many post-transcriptional regulatory events, including mRNA processing, localization, stability, and translation. Researchers study this function to understand how cells decode mRNA sequence information and how dysregulation contributes to disease. The QuickGO definition emphasizes that binding depends on a specific nucleotide composition or sequence motif, which is a key feature for experimental design and interpretation. Because sequence-specific mRNA binding is often mediated by RNA-binding proteins (RBPs) and structured RNA elements, it is a central topic in RNA biology and therapeutic development.
sequence-specific mRNA binding At A Glance
| GO ID | GO:1990825 |
|---|---|
| GO term | sequence-specific mRNA binding |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binding to messenger RNA (mRNA) of a specific nucleotide composition or a specific sequence motif. |
| Major function | Selective recognition of mRNA sequences or motifs to regulate post-transcriptional events. |
| Example mechanism | Sequence-specific endoribonucleases and RNA-binding proteins that recognize defined mRNA motifs. |
| Related processes | mRNA processing, mRNA stability, translation, RNA localization. |
| Experimental relevance | CRISPR knockout, point mutation, knock-in, and overexpression models can test causality of sequence-specific mRNA-binding factors. |
What Is GO:1990825?
In our own words, GO:1990825 sequence-specific mRNA binding is the molecular function of physically interacting with an mRNA molecule in a way that requires a particular nucleotide sequence or base composition. This is not merely binding to RNA in general; it is binding that discriminates between different mRNA sequences or motifs. The function can be executed by proteins, protein complexes, or structured RNAs that recognize specific mRNA elements. It is a molecular activity that contributes to larger processes such as mRNA processing, stability, and translation.
Why Is sequence-specific mRNA binding Important in Cell Biology?
Sequence-specific mRNA binding is important because it provides the molecular basis for selective post-transcriptional control. Without sequence-specific recognition, cells could not distinguish among thousands of mRNAs to regulate their processing, stability, or translation. This function is also directly relevant to disease mechanisms, as altered sequence-specific mRNA binding can contribute to cancer, neurological disorders, and other conditions. Understanding it enables researchers to design targeted interventions and to interpret RNA-based experimental data with confidence.
• Enables selective regulation of mRNA processing and maturation.
• Supports mRNA stability and decay decisions in response to cellular signals.
• Facilitates mRNA localization and translation control.
• Provides a mechanism for sequence-specific endoribonuclease activity in toxin-antitoxin systems.
• Underlies RNA-RNA and RNA-protein interaction networks that shape the transcriptome.
• Is a key consideration in interpreting RNA-binding protein specificity.
• Contributes to disease when sequence-specific recognition is disrupted.
• Offers a target for therapeutic modulation of mRNA fate.
• Guides experimental design for CRISPR-based functional studies.
• Helps explain non-canonical RNA-binding activities that may not be sequence-specific.
What Happens During sequence-specific mRNA binding?
Recognition of mRNA sequence or motif
In simple terms: The binding factor finds and recognizes a specific sequence or pattern in the mRNA.
Sequence-specific mRNA binding begins with the recognition of a defined nucleotide sequence or composition within the mRNA. This recognition can be mediated by RNA-binding proteins or by structured RNA elements that form sequence-dependent contacts. The specificity distinguishes this function from nonspecific RNA binding, which is often driven by electrostatic interactions. In some systems, the recognition motif is short and degenerate, while in others it is highly defined.
Formation of stable binding complexes
In simple terms: Once recognized, the factor and mRNA form a stable complex.
After initial recognition, the binding factor and mRNA form a stable complex. This step may involve conformational changes in the protein or RNA, and it can be influenced by cofactors or RNA modifications. Stable binding is required for downstream functional outcomes such as cleavage, processing, or translational control. The stability of the complex often depends on the exact sequence context.
Functional consequences for mRNA fate
In simple terms: The binding event changes what happens to the mRNA.
Sequence-specific mRNA binding can lead to diverse outcomes, including endonucleolytic cleavage, 3' processing, altered stability, or changes in translation efficiency. For example, mRNA interferases bind and cleave mRNA at specific sequences, thereby inhibiting protein synthesis. In other cases, sequence-specific binding by processing machinery can influence polyadenylation site choice. These outcomes are context-dependent and rely on the precise sequence recognized.
Regulation by RNA-RNA interactions
In simple terms: Other RNAs can help or hinder the binding process.
Sequence-specific mRNA binding is not always a simple protein-RNA event; it can be regulated by RNA-RNA interactions. MALAT1, for instance, regulates mRNA processing through sequence-dependent RNA-RNA and RNA-protein interactions. Such interactions can sequester or present binding motifs, thereby modulating the accessibility of the mRNA to sequence-specific factors. This layer of regulation adds complexity to how sequence-specific binding is achieved in cells.
Specificity and non-canonical binders
In simple terms: Not all RNA binders are sequence-specific, and some lack classic RNA-binding domains.
Many RNA-binding proteins lack canonical RNA-binding domains, and such proteins are rarely sequence-specific. This observation highlights that sequence-specific mRNA binding often requires dedicated domains or structural features that confer selectivity. When non-canonical binders do show specificity, it may arise from indirect interactions or complex formation. Understanding these distinctions is critical for interpreting RNA interaction data.
Key Genes Involved in GO:1990825 sequence-specific mRNA binding
The following genes and proteins are representative examples of factors that carry out or regulate sequence-specific mRNA binding, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MALAT1 | Regulates mRNA processing through sequence-dependent RNA-RNA and RNA-protein interactions | Model for studying RNA-RNA regulation of sequence-specific binding |
| T4 DNA polymerase | Binds its own mRNA with nucleotide-sequence-specific and non-specific interactions | Classic example of sequence-specific mRNA binding by a DNA polymerase |
| Lutropin receptor (LHR) mRNA-binding protein | Binds cytidine-rich sequences in the lutropin receptor open reading frame | Hormonally regulated sequence-specific mRNA binding model |
| mRNA interferases (toxin-antitoxin systems) | Sequence-specific endoribonucleases that bind and cleave mRNA | Model for sequence-specific mRNA cleavage and translation inhibition |
| mRNA 3' processing machinery | Reveals hidden sequence specificity in 3' processing | Target for understanding sequence-specific recognition in polyadenylation |
| oskar | Architectural role of specific RNA-RNA interactions in oskar granules | Model for sequence-specific RNA interactions in localization |
| JTE-607 target complex | Anticancer compound reveals sequence specificity of mRNA 3' processing machinery | Chemical biology tool to probe sequence-specific mRNA binding |
| Novel sequence-specific single-stranded-DNA-binding protein | Cloned and characterized as sequence-specific single-stranded-DNA-binding protein | Related example of sequence-specific nucleic acid binding |
| Canonical RNA-binding proteins (RBPs) | Often mediate sequence-specific mRNA binding via canonical domains | Benchmark for specificity studies |
| Non-canonical RNA-binding proteins | Rarely sequence-specific, highlighting domain requirements | Negative controls for specificity assays |
| Cytidine-rich sequence-binding proteins | Bind cytidine-rich sequences in mRNA | Model for sequence composition-dependent binding |
| Toxin-antitoxin endoribonucleases | Cleave mRNA at specific sequences | Antibacterial target research |
| mRNA processing factors | Recognize sequence motifs during 3' end formation | Cancer and gene expression studies |
| RNA-RNA interaction scaffolds | Facilitate sequence-dependent mRNA regulation | Study of lncRNA-mRNA networks |
| oskar granule components | Form sequence-specific RNA-RNA interactions | Developmental biology and RNA granule research |
| T4 DNA polymerase mRNA | Acts as a target for sequence-specific binding | Bacteriophage model for mRNA recognition |
| LHR mRNA | Contains cytidine-rich motifs bound by specific proteins | Reproductive biology and hormone regulation |
| ssDNA-binding protein (novel) | Shows sequence-specific binding to single-stranded nucleic acids | Comparative studies of sequence-specific nucleic acid recognition |
How Is sequence-specific mRNA binding Regulated?
Sequence-specific mRNA binding can be regulated at multiple levels. RNA-RNA interactions, such as those mediated by MALAT1, can modulate the accessibility of mRNA motifs and thereby influence binding by sequence-specific factors. The presence of non-canonical RNA-binding proteins that are rarely sequence-specific suggests that specificity is often conferred by dedicated domains or complex assembly. Additionally, chemical compounds like JTE-607 can reveal hidden sequence specificity in the mRNA 3' processing machinery, indicating that small molecules can modulate these interactions. Hormonal regulation has also been observed for a cytidine-rich sequence-binding protein, linking sequence-specific mRNA binding to physiological signals.
sequence-specific mRNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| mRNA 3' processing machinery | Cancer (mRNA processing dysregulation) | Knockout of processing factors in cancer cell lines |
| MALAT1 | Cancer and RNA processing | Knockdown or knockout in cancer models |
| mRNA interferases | Bacterial infection and persistence | Bacterial toxin-antitoxin knockout strains |
| oskar | Developmental disorders (RNA localization) | Knock-in of tagged oskar in model organisms |
| LHR mRNA-binding protein | Reproductive disorders (hormonal regulation) | Point mutation of binding motif in cell models |
Cancer and mRNA processing
Sequence-specific mRNA binding by the 3' processing machinery can be targeted by anticancer compounds such as JTE-607, which reveals hidden sequence specificity. Dysregulation of mRNA processing factors may contribute to oncogenesis by altering the fate of specific mRNAs. Studying sequence-specific binding in cancer cells can identify vulnerabilities in mRNA maturation pathways.
Neurological and developmental disorders
Sequence-specific RNA-RNA interactions, such as those in oskar granules, are critical for developmental processes. Disruption of these interactions can affect mRNA localization and translation, which are important in neuronal function and development. Although direct disease links are still emerging, the architectural role of specific RNA-RNA interactions suggests that their perturbation may contribute to developmental disorders.
Infectious disease and toxin-antitoxin systems
mRNA interferases from toxin-antitoxin systems are sequence-specific endoribonucleases that bind and cleave mRNA, leading to growth inhibition. These systems are potential antibacterial targets, and understanding their sequence specificity can inform drug development. Sequence-specific mRNA binding is therefore directly relevant to bacterial pathogenesis and persistence.
From sequence-specific mRNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a sequence-specific mRNA-binding protein affect mRNA stability? | CRISPR knockout cell line |
| Does a specific point mutation abolish sequence-specific binding? | Point-mutation knock-in cell line |
| Can a tagged version of the protein rescue the phenotype? | Tagged knock-in cell line |
| Does overexpression of the protein alter mRNA processing? | Overexpression cell model |
| Which mRNAs are bound by the protein in vivo? | CRISPR knockout with RNA immunoprecipitation |
| Does a chemical compound modulate sequence-specific binding? | Wild-type and mutant cell lines treated with compound |
How to Study the sequence-specific mRNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RIP-seq | mRNAs bound by a protein in vivo | Mapping sequence-specific binding sites |
| EMSA | Direct binding of protein to RNA motif | Confirming sequence specificity |
| CRISPR knockout | Loss-of-function effects on mRNA binding | Causal testing of candidate genes |
| RNA-seq | Transcriptome-wide changes | Assessing downstream effects of binding |
| CLIP-seq | Protein-RNA crosslinking sites | High-resolution mapping of binding motifs |
| In vitro cleavage assay | Sequence-specific endoribonuclease activity | Studying mRNA interferases |
| Reporter assays | Translational or stability effects of binding | Functional validation of motifs |
| Structural biology (cryo-EM/X-ray) | 3D structure of protein-RNA complex | Mechanistic understanding of specificity |
RNA immunoprecipitation and sequencing
RNA immunoprecipitation followed by sequencing (RIP-seq) can identify mRNAs bound by a specific protein in cells. This method is useful for mapping sequence-specific binding sites and for comparing wild-type and mutant conditions. It can be combined with CRISPR knockout to validate specificity.
In vitro binding assays
Electrophoretic mobility shift assays (EMSAs) and filter-binding assays can measure direct sequence-specific binding of purified proteins to synthetic mRNA motifs. These assays are essential for confirming that binding depends on a specific sequence. They can also test the effect of point mutations in the protein or RNA.
CRISPR-based functional screens
CRISPR knockout and interference screens can identify genes required for sequence-specific mRNA binding and its downstream effects. Such screens are powerful for discovering novel factors and for linking binding to phenotypes. They can be paired with RNA-seq to assess transcriptome-wide consequences.
Structural and biochemical approaches
Structural biology methods such as X-ray crystallography and cryo-EM can reveal how proteins recognize specific mRNA sequences. Biochemical assays can measure binding affinity and kinetics. These approaches provide mechanistic insight into sequence specificity.
How CRISPR Can Be Used to Study GO:1990825 sequence-specific mRNA binding
Knockout
CRISPR knockout of genes encoding sequence-specific mRNA-binding proteins can reveal their essential functions and identify the mRNAs they regulate. Knockout cell lines are valuable for comparing binding profiles and downstream phenotypes. They also serve as negative controls in binding assays.
Point Mutation
Point mutations can be introduced into the RNA-binding domain or the mRNA motif to test the requirement for specific residues or sequences. This approach helps distinguish sequence-specific binding from nonspecific interactions. Point-mutation models are also useful for studying disease-associated variants.
Knock-in
Knock-in of tagged versions of sequence-specific mRNA-binding proteins allows for affinity purification and localization studies. Tagged knock-in models preserve endogenous regulation and can be used for RIP-seq or imaging. They are also useful for rescuing knockout phenotypes.
Overexpression
Overexpression of a sequence-specific mRNA-binding protein can amplify its effects on mRNA fate and reveal gain-of-function phenotypes. This is particularly useful when the protein is normally expressed at low levels. Overexpression models can also be used to test dominant-negative mutants.
How EDITGENE Supports sequence-specific mRNA binding Research
Researchers studying sequence-specific mRNA binding-related genes often need to determine whether a candidate gene is causally involved in a specific RNA regulatory pathway. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for sequence-specific mRNA binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NOVA1 Knockout HEK293 Cell Line | EDJ-KQ175 | Human | 4857 | Details Get a Quote |
| NOVA2 Knockout HEK293 Cell Line | EDJ-KQ180 | Human | 4858 | Details Get a Quote |
| FMR1 Knockout HEK293T Cell Line | EDJ-KQ215 | Human | 2332 | Details Get a Quote |
| RBM24 Knockout HEK293 Cell Line | EDJ-KQ2662 | Human | 221662 | Details Get a Quote |
| L1TD1 Knockout HEK293 Cell Line | EDJ-KQ3294 | Human | 54596 | Details Get a Quote |
| FMR1 Knockout HEK293 Cell Line | EDJ-KQ3472 | Human | 2332 | Details Get a Quote |
| SRSF4 Knockout HEK293 Cell Line | EDJ-KQ5739 | Human | 6429 | Details Get a Quote |
| LARP6 Knockout HEK293 Cell Line | EDJ-KQ14027 | Human | 55323 | Details Get a Quote |
| LIN28A Knockout HEK293 Cell Line | EDJ-KQ14079 | Human | 79727 | Details Get a Quote |
| TYMS Knockout HEK293 Cell Line | EDJ-KQ17847 | Human | 7298 | Details Get a Quote |
| NOVA1 Knockout A-549 Cell Line | EDJ-KQ19985 | Human | 4857 | Details Get a Quote |
| SRSF4 Knockout A-549 Cell Line | EDJ-KQ29135 | Human | 6429 | Details Get a Quote |
| SRSF4 Knockout HCT 116 Cell Line | EDJ-KQ29136 | Human | 6429 | Details Get a Quote |
| SRSF4 Knockout HeLa Cell Line | EDJ-KQ29137 | Human | 6429 | Details Get a Quote |
| LARP6 Knockout HCT 116 Cell Line | EDJ-KQ43940 | Human | 55323 | Details Get a Quote |
Displaying Records 1 To 15 Of 46 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About sequence-specific mRNA binding
What is GO:1990825 sequence-specific mRNA binding?
GO:1990825 is a molecular function term describing the binding to messenger RNA (mRNA) of a specific nucleotide composition or a specific sequence motif.
What genes are involved in sequence-specific mRNA binding?
Genes include MALAT1, mRNA interferases, T4 DNA polymerase, and components of the mRNA 3' processing machinery, among others.
How is sequence-specific mRNA binding different from general RNA binding?
Sequence-specific binding depends on a particular nucleotide sequence or composition, whereas general RNA binding may be driven by nonspecific electrostatic interactions.
What diseases are linked to sequence-specific mRNA binding?
Dysregulation has been implicated in cancer, developmental disorders, and bacterial infections through toxin-antitoxin systems.
What methods are used to study sequence-specific mRNA binding?
Common methods include RIP-seq, EMSA, CRISPR knockout, and structural biology approaches.
Can CRISPR be used to study sequence-specific mRNA binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to test the function of sequence-specific mRNA-binding factors.
What is an example of a sequence-specific mRNA-binding protein?
mRNA interferases are classic examples of sequence-specific endoribonucleases that bind and cleave mRNA at defined motifs.
How does MALAT1 regulate sequence-specific mRNA binding?
MALAT1 regulates mRNA processing through sequence-dependent RNA-RNA and RNA-protein interactions.
Are non-canonical RNA-binding proteins sequence-specific?
Proteins that lack canonical RNA-binding domains are rarely sequence-specific, highlighting the importance of dedicated domains for specificity.
What is the role of sequence-specific mRNA binding in translation?
It can control translation by influencing mRNA stability, localization, or processing, as seen in various systems.
Conclusion
GO:1990825 sequence-specific mRNA binding is a fundamental molecular function that enables selective recognition of mRNA sequences or motifs. It underlies diverse post-transcriptional regulatory events and is mediated by both canonical and non-canonical RNA-binding factors. Understanding its mechanisms has broad implications for RNA biology, disease research, and therapeutic development. CRISPR-based models and advanced sequencing methods continue to illuminate how sequence-specific mRNA binding shapes gene expression.
References
- 1. Ray D et al.. 2023. RNA-binding proteins that lack canonical RNA-binding domains are rarely sequence-specific.. Sci Rep 13(1):5238 PMID: 37002329
- 2. Yamaguchi Y et al.. 2009. mRNA interferases, sequence-specific endoribonucleases from the toxin-antitoxin systems.. Prog Mol Biol Transl Sci 85:467-500 PMID: 19215780
- 3. Balaji A et al.. 2025. MALAT1 regulates mRNA processing through sequence dependent RNA-RNA and RNA-protein interactions.. Nucleic Acids Res 53(15) PMID: 40808300
- 4. Liu L et al.. 2023. The anticancer compound JTE-607 reveals hidden sequence specificity of the mRNA 3' processing machinery.. Nat Struct Mol Biol 30(12):1947-1957 PMID: 38087090
- 5. Bose M et al.. 2024. An architectural role of specific RNA-RNA interactions in oskar granules.. Nat Cell Biol 26(11):1934-1942 PMID: 39354131
- 6. Pavlov AR et al.. 2000. Nucleotide-sequence-specific and non-specific interactions of T4 DNA polymerase with its own mRNA.. Nucleic Acids Res 28(23):4657-64 PMID: 11095675
- 7. Kash JC et al.. 1999. Sequence-specific binding of a hormonally regulated mRNA binding protein to cytidine-rich sequences in the lutropin receptor open reading frame.. Biochemistry 38(51):16889-97 PMID: 10606523
- 8. Bayarsaihan D et al.. 1998. Cloning and characterization of a novel sequence-specific single-stranded-DNA-binding protein.. Biochem J 331 ( Pt 2)(Pt 2):447-52 PMID: 9531483
